BF.7 Omicron subvariant in India and China: a raising concern - correspondence.
作者信息
Sah Ranjit, Mohanty Aroop, Rohilla Ranjana, Padhi Bijay K
机构信息
Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.
D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra.
出版信息
Int J Surg. 2023 Mar 1;109(3):606-607. doi: 10.1097/JS9.0000000000000194.
Abstract
摘要
相似文献
1
BF.7 Omicron subvariant in India and China: a raising concern - correspondence.印度和中国的BF.7奥密克戎亚变体：一个日益引起关注的问题——通信
Int J Surg. 2023 Mar 1;109(3):606-607. doi: 10.1097/JS9.0000000000000194.
2
Clinical characteristics of 909 cases infected by Omicron BF.7 variant in Hohhot of China: A retrospective study.中国呼和浩特909例感染奥密克戎BF.7变异株病例的临床特征：一项回顾性研究
Medicine (Baltimore). 2025 Jun 20;104(25):e42794. doi: 10.1097/MD.0000000000042794.
3
A commentary on 'BF.7 Omicron subvariant (BA.5.2.1.7) posing fears of a rise in COVID-19 cases again: a critical appraisal and salient counteracting strategies'.关于“BF.7奥密克戎亚变体（BA.5.2.1.7）引发对新冠病例再次上升的担忧：批判性评估及显著应对策略”的评论
Int J Surg. 2024 Jan 1;110(1):582-583. doi: 10.1097/JS9.0000000000000766.
4
Current surge of COVID-19 infection in China and its impact on India.中国当前 COVID-19 感染的激增及其对印度的影响。
Indian J Med Microbiol. 2023 Mar-Apr;42:46-48. doi: 10.1016/j.ijmmb.2023.01.010. Epub 2023 Feb 2.
5
A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.一项关于原型疫苗、单价适配疫苗和二价疫苗针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）野生型、奥密克戎BA.1和奥密克戎BA.4/5在健康成年人中的免疫原性的荟萃分析。
Virology. 2025 May;606:110509. doi: 10.1016/j.virol.2025.110509. Epub 2025 Mar 19.
6
Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.临床病毒学以及 COVID-19 疫苗和单克隆抗体对高传染性 SARS-CoV-2 奥密克戎变异株 BF.7（BA.5.2.1.7）的影响：系统评价。
Virology. 2023 Jul;584:38-43. doi: 10.1016/j.virol.2023.04.007. Epub 2023 May 19.
7
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.社论：奥密克戎 SARS-CoV-2 的 XBB.1.5（“Kraken”）亚变体及其快速全球传播。
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
8
Genetic and Immunological Profiling of Recent SARS-CoV-2 Omicron Subvariants: Insights into Immune Evasion and Infectivity in Monoinfections and Coinfections.新冠病毒奥密克戎变种新亚型的基因和免疫特征分析：单重感染和合并感染中免疫逃逸及传染性的见解
Viruses. 2025 Jun 27;17(7):918. doi: 10.3390/v17070918.
9
Dynamics of neutralizing antibodies against COVID-19 Omicron subvariants following breakthrough infection in southwest China between December 2022 and April 2024.2022年12月至2024年4月中国西南部突破性感染后针对新冠病毒奥密克戎亚变体的中和抗体动态变化
Signal Transduct Target Ther. 2025 Jul 30;10(1):242. doi: 10.1038/s41392-025-02319-3.
10
Dynamic monitoring of antibody titers in people living with HIV during Omicron epidemic: comparison between unvaccinated and vaccinated individuals.奥密克戎疫情期间HIV感染者抗体滴度的动态监测：未接种疫苗者与接种疫苗者的比较
BMC Infect Dis. 2025 Jul 30;25(1):962. doi: 10.1186/s12879-025-11387-3.
引用本文的文献
1
Retrospective study about clinical severity and epidemiological analysis of the COVID-19 Omicron subvariant lineage-infected patients in Hohhot, China.关于呼和浩特市感染新冠病毒奥密克戎变异株的 COVID-19 患者临床严重程度和流行病学分析的回顾性研究。
BMC Infect Dis. 2024 Feb 15;24(1):206. doi: 10.1186/s12879-024-09084-8.
2
Newer emerging SARS-COV2 variant: Omicron EG.5.新出现的新冠病毒变异株：奥密克戎EG.5
Ann Med Surg (Lond). 2023 Oct 4;85(12):5845-5846. doi: 10.1097/MS9.0000000000001386. eCollection 2023 Dec.
Zotero 插件